AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Quarter Return
-5.2%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$176M
AUM Growth
+$176M
(-2.2%)
Cap. Flow
+$6.06M
Cap. Flow
% of AUM
3.44%
Top 10 Holdings %
Top 10 Hldgs %
22.12%
Holding
256
New
24
Increased
39
Reduced
132
Closed
21
Top Buys
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
$3.22M |
| 2 |
uniQure
QURE
|
$2.31M |
| 3 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
$2.18M |
| 4 |
TSVT
2seventy bio
TSVT
|
$1.87M |
| 5 |
Embecta
EMBC
|
$1.71M |
Top Sells
| 1 |
AdaptHealth
AHCO
|
$3.44M |
| 2 |
Elanco Animal Health
ELAN
|
$2.97M |
| 3 |
Centene
CNC
|
$2.7M |
| 4 |
iShares MBS ETF
MBB
|
$2.05M |
| 5 |
Lantheus
LNTH
|
$1.93M |
Sector Composition
| 1 | Healthcare | 61.76% |
| 2 | Real Estate | 10.3% |
| 3 | Financials | 3.56% |
| 4 | Technology | 3.07% |
| 5 | Energy | 2.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBA
1
DELISTED
Walgreens Boots Alliance
WBA
| $5M | 2.84% |
225,000
+145,000
| +181% | +$3.22M |
|
2
Rithm Capital
RITM
$6.57B
| $4.71M | 2.67% |
507,277
+15,578
| +3% | +$145K |
|
3
BioCryst Pharmaceuticals
BCRX
$1.74B
| $4.59M | 2.61% |
649,000
+79,000
| +14% | +$559K |
|
4
Harmony Biosciences
HRMY
$2.12B
| $4M | 2.27% |
122,000
+4,000
| +3% | +$131K |
|
5
iShares 1-3 Year Treasury Bond ETF
SHY
$24.5B
| $3.66M | 2.08% |
45,190
+18,397
| +69% | +$1.49M |
|
6
Galapagos
GLPG
$2.07B
| $3.63M | 2.06% |
105,000
+6,000
| +6% | +$207K |
|
7
Jazz Pharmaceuticals
JAZZ
$7.75B
| $3.43M | 1.95% |
26,500
-14,250
| -35% | -$1.84M |
|
8
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $3.41M | 1.94% |
912,500
| – | – |
|
9
Neurocrine Biosciences
NBIX
$13.8B
| $3.38M | 1.91% |
30,000
-6,500
| -18% | -$731K |
|
10
Pacira BioSciences
PCRX
$1.2B
| $3.16M | 1.79% |
103,000
+46,500
| +82% | +$1.43M |
|
|
11
Embecta
EMBC
$847M
| $3.12M | 1.77% |
207,000
+113,500
| +121% | +$1.71M |
|
|
EFC
12
Ellington Financial
EFC
$1.36B
| $2.98M | 1.69% |
239,271
| – | – |
|
|
HZNP
13
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $2.95M | 1.67% |
25,500
| – | – |
|
14
Ironwood Pharmaceuticals
IRWD
$214M
| $2.82M | 1.6% |
292,500
+135,000
| +86% | +$1.3M |
|
15
Amylyx Pharmaceuticals
AMLX
$836M
| $2.66M | 1.51% |
145,500
+37,500
| +35% | +$687K |
|
|
16
uniQure
QURE
$896M
| $2.63M | 1.49% |
391,500
+344,000
| +724% | +$2.31M |
|
|
TSVT
17
DELISTED
2seventy bio
TSVT
| $2.58M | 1.46% |
657,500
+477,500
| +265% | +$1.87M |
|
18
Crinetics Pharmaceuticals
CRNX
$2.92B
| $2.44M | 1.38% |
82,000
+35,000
| +74% | +$1.04M |
|
19
UroGen Pharma
URGN
$900M
| $2.31M | 1.31% |
165,000
+12,500
| +8% | +$175K |
|
|
RVNC
20
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.18M | 1.24% |
+190,000
| New | +$2.18M |
|
|
DX
21
Dynex Capital
DX
$1.64B
| $2.17M | 1.23% |
181,492
+28,000
| +18% | +$334K |
|
22
Invesco S&P 500 Pure Value ETF
RPV
$1.36B
| $2.15M | 1.22% |
29,285
-1,926
| -6% | -$142K |
|
23
iShares Russell 1000 Value ETF
IWD
$63.5B
| $2.15M | 1.22% |
14,193
-812
| -5% | -$123K |
|
24
United Therapeutics
UTHR
$13.8B
| $2.03M | 1.15% |
9,000
| – | – |
|
25
Insmed
INSM
$28.8B
| $2.02M | 1.15% |
80,000
-15,000
| -16% | -$379K |
|